ArticleJournal of healthcare engineering2017
Twin SVM-Based Classification of Alzheimer's Disease Using Complex Dual-Tree Wavelet Principal Coefficients and LDA.
Article in Journal of healthcare engineering, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- A New Proposed Approach to Categorize Sepsis Sub-phenotypes Based on Combined Trajectories of Perfusion Index and Central Venous Oxygen Saturation.Shock (Augusta, Ga.) · 2026Article
- Deep Learning for Alzheimer's Disease Prediction: A Comprehensive Review.Diagnostics (Basel, Switzerland) · 2024Review
- PPAD: a deep learning architecture to predict progression of Alzheimer's disease.Bioinformatics (Oxford, England) · 2023Article
- The Application of DTCWT on MRI-Derived Radiomics for Differentiation of Glioblastoma and Solitary Brain Metastases.Journal of personalized medicine · 2022Article
- Deep Learning-Based Diagnosis of Alzheimer's Disease.Journal of personalized medicine · 2022Review
- A new classification network for diagnosing Alzheimer's disease in class-imbalance MRI datasets.Frontiers in neuroscience · 2022Article
- Comparison of machine learning approaches for enhancing Alzheimer's disease classification.PeerJ · 2021Article
- Prediction of Cognitive Decline in Temporal Lobe Epilepsy and Mild Cognitive Impairment by EEG, MRI, and Neuropsychology.Computational intelligence and neuroscience · 2020Article
- Feature Selection and Combination of Information in the Functional Brain Connectome for Discrimination of Mild Cognitive Impairment and Analyses of Altered Brain Patterns.Frontiers in aging neuroscience · 2020Article
- Morphological Neuroimaging Biomarkers for Tinnitus: Evidence Obtained by Applying Machine Learning.Neural plasticity · 2019Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
Alzheimer's disease (AD) is a leading cause of dementia, which causes serious health and socioeconomic problems. A progressive neurodegenerative disorder, Alzheimer's causes the structural change in the brain, thereby affecting behavior, cognition, emotions, and memory. Numerous multivariate analysis algorithms have been used for classifying AD, distinguishing it from healthy controls (HC). Efficient early classification of AD and mild cognitive impairment (MCI) from HC is imperative as early preventive care could help to mitigate risk factors. Magnetic resonance imaging (MRI), a noninvasive biomarker, displays morphometric differences and cerebral structural changes. A novel approach for distinguishing AD from HC using dual-tree complex wavelet transforms (DTCWT), principal coefficients from the transaxial slices of MRI images, linear discriminant analysis, and twin support vector machine is proposed here. The prediction accuracy of the proposed method yielded up to 92.65 ± 1.18 over the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset, with a specificity of 92.19 ± 1.56 and sensitivity of 93.11 ± 1.29, and 96.68 ± 1.44 over the Open Access Series of Imaging Studies (OASIS) dataset, with a sensitivity of 97.72 ± 2.34 and specificity of 95.61 ± 1.67. The accuracy, sensitivity, and specificity achieved using the proposed method are comparable or superior to those obtained by various conventional AD prediction methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.